Loading clinical trials...
Loading clinical trials...
Retrospective observational study: impact of a peri-operative patient blood management program (PBM) on transfusion rates of patients undergoing elective hip replacement.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Istituto Ortopedico Rizzoli
NCT07072247 · Refractory Immune-mediated Platelet Transfusion Refractoriness, Relapsed or Refractory Immune Thrombocytopenia
NCT06840756 · Red Blood Cell Transfusions, Sex Differences, and more
NCT07466719 · Obstetric Hemostasis, Intravascular Hemolysis, and more
NCT07341139 · Transfusion Adverse Reaction, Major Trauma, and more
NCT07097337 · Trauma Induced Coagulopathy, Trauma Coagulopathy, and more
Sandra Giannone
Bologna, BO
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions